Expression of epidermal growth factor receptor in primary colorectal adenocarcinoma predicts expression in recurrent disease

American Journal of Clinical Pathology

Volumn 125, Issue 2, 2006, Pages 229-233

  Khalifa, Mahmoud A ^a   Rowsell, Corwyn H ^a   Gladdy, Rebecca A ^a   Ko, Yoo Joung ^a   Hanna, Sherif ^a   Smith, Andy ^a   Law, Calvin ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Colorectal cancer; EGFR; Epidermal growth factor receptor; Immunohistochemistry; Metastasis; Recurrence; Targeted therapy

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; COLORECTAL CARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LOGISTIC REGRESSION ANALYSIS; MALE; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; RELIABILITY; TISSUE SECTION; TUMOR RECURRENCE;

EID: 31544463523     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/HV7V1MJXV8Y8989W     Document Type: Article

References (18)

1. Meyerhardt JA, Mayer RJ. Systemic therapy for colorectal cancer. N Engl J Med. 2005;352:476-487.
2. Salomon DS, Brandt R, Cardiello F, et al. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol. 1995;19:183-232.
3. Carpenter G, Cohen S. Epidermal growth factor. J Biol Chem. 1990;265:7709-7712.
4. Real FX, Rettig WJ, Chesa PG, et al. Expression of epidermal growth factor receptor in human cultured cells and tissues: relationship to cell lineage and stage of differentiation. Cancer Res. 1986;46:4726-4731.
5. Marmor MD, Skaria KB, Yarden Y. Signal transduction and oncogenesis by ErbB/HER receptors. Int J Radiat Oncol Biol Phys. 2004;58:903-913.
6. Thomas SM, Grandis JR. Pharmacokinetic and pharmacodynamic properties of EGFR inhibitors under clinical investigation. Cancer Treat Rev. 2004;30:255-268.
7. Saltz L, Hochster H, Rubin M, et al. Cetuximab (IMC-C225) plus irinotecan (CPT-11) is active in CPT-11-refractory colorectal cancer (CRC) that expresses epidermal growth factor receptor (EGFR) [abstract]. Proc Am Soc Clin Oncol. 2001;20:3a. Abstract 7.
8. Saltz L, Meropol N, Loehrer P, et al. Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor. J Clin Oncol. 2004;22:1201-1208.
9. Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med. 2004;351:337-345.
10. Chung K, Shia J, Kemeny N, et al. Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry. J Clin Oncol. 2005;23:1803-1810.
11. Johnson GA, Mannel R, Khalifa M, et al. Epidermal growth factor receptor in vulvar malignancies and its relationship to metastasis and patient survival. Gynecol Oncol. 1997;65:425-429.
12. Italiano A, Saint-Paul MC, Caroli-Bosc FX, et al. Epidermal growth factor receptor (EGFR) status in primary colorectal tumors correlates with EGFR expression in related metastatic sites: biological and clinical implications. Ann Oncol. 2005;16:1503-1507.
13. Scartozzi M, Bearzi I, Berardi R, et al. Epidermal growth factor receptor (EGFR) status in primary colorectal tumors does not correlate with EGFR expression in related metastatic sites: implications for treatment with EGFR-targeted monoclonal antibodies. J Clin Oncol. 2004;22:4772-4778.
14. Banerjee D, Guba AK, Guindi MM, et al. Best Practice Standards for EGFR Testing in Colorectal Cancer in Canada. SNELL Medical Communication for Bristol-Myers Squibb Canada. 2005. Pamphlet 600-149.
15. Karameris A, Kanaveros P, Aninos D, et al. Expression of epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) in gastric and colorectal carcinomas: an immunohistological study of 63 cases. Pathol Res Pract. 1993;189:133-137.
16. Mayer A, Takimoto M, Fritz E, et al. The prognostic significance of proliferating cell nuclear antigen, epidermal growth factor receptor, and mdr gene expression in colorectal cancer. Cancer. 1993;71:2454-2460.
17. Radinsky R, Risin S, Fan D, et al. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res. 1995;1:19-31.
18. Venook AP. Epidermal growth factor receptor-targeted treatment for advanced colorectal carcinoma. Cancer. 2005;103:2435-2446.